Illumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease
/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the release of Connected...
Source: prnewswire.com